National Cancer Institute
Untracked preview. This is not a tracked Signal Bureau entity — the page is generated on request from live coverage search, is not indexed, and carries no editorial curation. Tracked entities live on the Wire.
If National Cancer Institute is on your watch list: what changed in the coverage, what the reporting asserts, and what the crowd is pricing.
What’s changed
- National Cancer Institute: Colon Cancer Treatment (PDQ®)–Patient Version · PDQ® · 2026-09-06
- IASLC WCLC 2026 · The ASCO Post · 2026-09-02
- September 2026 · The ASCO Post · 2026-09-01
- High-Dose Vitamin D3 Does Not Improve PFS in Metastatic Colorectal Cancer · The ASCO Post · 2026-08-31
- Study Evaluates Chemotherapy-Free Quadruplet in HR-Positive, HER2-Positive Metastatic Breast Cancer · The ASCO Post · 2026-08-27
- Prostate Cancer NRG-GU005 Defines Trade-Offs Between SBRT and Moderately Hypofractionated IMRT · The ASCO Post · 2026-08-27
What the reporting says
It shows up alongside Cancer Center (8), Her2 (9), ASCO (8), Colorectal Cancer (10), Immunotherapy (9), Lung Cancer (9).
Two steps out: Braf (through Colorectal Cancer, 10 shared stories on the weaker link); Chen (through Colorectal Cancer, 10 shared stories on the weaker link); ctDNA (through Colorectal Cancer, 10 shared stories on the weaker link); Egfr (through Colorectal Cancer, 10 shared stories on the weaker link).
Tracked since Aug 3, with coverage on 16 separate days — concentrated in Society News and Industry News.